Laila Samady Mustad
No más puestos en curso
Perfil
Laila is a research scientist, strategic advisor, and entrepreneur with 20 years’ experience in the pharmaceutical, medical, and biotechnology industry in the UK, US, and France.
Her expertise is in medical affairs, partnership, business development, and capital raising strategies.
She is Chair of the Board of Advisors and Chief Scientific Officer at Vigilent Labs (digital health), Vice President at Covanos (med tech), Vice President at G3 Therapeutics (biotech), and has held several senior partnership roles at Boehringer Ingelheim.
Laila holds a PhD from University College London and her work led to a spin out company, BioVex, which was acquired by Amgen for $1Bn.
Antiguos cargos conocidos de Laila Samady Mustad.
| Empresas | Cargo | Fin |
|---|---|---|
Ryse Asset Management LLP
 Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | Inversor de Capital Privado | - |
Formación de Laila Samady Mustad.
| University College London | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Ryse Asset Management LLP
Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | Finance |
- Bolsa de valores
- Insiders
- Laila Samady Mustad
